The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

17 May 2017 14:25

RNS Number : 4485F
Maven Income & Growth VCT 4 PLC
17 May 2017
 

 

Maven Income and Growth VCT 4 PLC

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at 10.30 am at Fifth Floor, 1-2 Royal Exchange Buildings, London, EC3V 3LF on 17 May 2017, all of the Resolutions put to the Meeting were duly passed.

 

At the record date for the Annual General Meeting, being 15 May 2017, the total number of voting rights in the Company stood at 32,767,502 Ordinary Shares. In accordance with the provisions of E.2.2 of the UK Corporate Governance Code, the Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 3,972,861 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Annual Report and audited Financial Statements.

3,854,111

104,885

0

13,865

3,972,861

2

To approve the Directors' Remuneration Report.

2,873,170

97,294

959,122

43,275

3,972,861

3

To approve the Directors' Remuneration Policy.

3,331,703

108,526

487,511

45,121

3,972,861

4

To approve a final dividend.

3,863,639

104,762

4,460

0

3,972,861

5

To re-elect Mr Cormack as a Director.

3,658,262

116,948

167,229

30,422

3,972,861

6

To re-elect Mr Graham-Wood as a Director.

3,654,209

122,020

166,210

30,422

3,972,861

7

To re-elect Mr Scott as a Director.

3,734,401

132,901

75,137

30,422

3,972,861

8

To re-elect Mr Nixon as a Director.

3,718,182

151,281

77,744

25,654

3,972,861

9

To re-appoint Deloitte LLP as Auditor.

3,420,186

160,474

380,571

11,630

3,972,861

10

To authorise the Directors to fix the remuneration of the Auditor.

3,794,009

141,724

17,998

19,130

3,972,861

11

To authorise the Directors to allot new shares.

3,787,895

131,600

22,735

30,631

3,972,861

12

To authorise disapplication of pre-emption rights.

3,627,875

131,600

125,146

88,240

3,972,861

13

To authorise the Company to purchase its own shares.

2,985,482

124,556

846,392

16,431

3,972,861

14

To allow a General Meeting to be called on not less than 14 days' notice.

3,446,170

387,084

117,313

22,294

3,972,861

 

The Board notes that Resolution 2, an Ordinary Resolution relating to the approval of the Directors' Remuneration Report, was duly passed but recognises that a significant minority of Shareholders have voted against the Resolution. It is intended that the Remuneration Committee will give this due consideration in its future deliberations

 

The Directors also note that Resolution 13, a Special Resolution relating to the buying back of shares, was duly passed, but once again recognise that a significant minority of Shareholders have voted against the Resolution. It is intended that the Board will consider the views expressed by Shareholders when it next seeks such an authority.

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. These proxy voting figures will also be available to view at: www.mavencp.com/migvct4.

 

 

 

 

Passing of Resolutions under Special Business

Copies of Resolutions passed under Special Business have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

17 May 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGBXGDUXDBBGRR
Date   Source Headline
19th Aug 20213:04 pmRNSStatement re NAV and Interim Dividend
16th Jun 20213:16 pmRNSStatement re Offer for Subscription
24th May 20214:45 pmRNSTransaction in Own Shares
21st May 202111:02 amRNSIssue of Equity
17th May 20214:32 pmRNSStatement re Dividend Investment Scheme
12th May 20214:08 pmRNSNet Asset Value(s)
12th May 202112:37 pmRNSResult of AGM
9th Apr 20215:48 pmRNSAnnual Financial Report
24th Feb 20214:20 pmRNSTransaction in Own Shares
23rd Feb 20214:18 pmRNSTransaction in Own Shares
17th Feb 20214:37 pmRNSStatement re NAV and Final Dividend
8th Dec 20203:27 pmRNSTransaction in Own Shares
17th Nov 20204:26 pmRNSTransaction in Own Shares
16th Nov 20204:52 pmRNSTransaction in Own Shares
11th Nov 20205:01 pmRNSNet Asset Value(s)
2nd Oct 202012:41 pmRNSIssue of Equity
29th Sep 20204:49 pmRNSStatement re Dividend Investment Scheme
1st Sep 20204:35 pmRNSTransaction in Own Shares
28th Aug 20202:38 pmRNSHalf-year Report
26th Aug 20205:26 pmRNSTransaction in Own Shares
20th Aug 202011:38 amRNSStatement re NAV, Interim Dividend and DIS
20th Aug 202011:29 amRNSDirector Declaration
9th Jul 202010:00 amRNSIssue of Equity
8th Jun 20209:36 amRNSAllotment Update
21st May 202012:17 pmRNSResult of AGM
15th May 20204:10 pmRNSNet Asset Value(s)
7th May 20204:35 pmRNSPublication of Suppl.Prospcts
21st Apr 20206:24 pmRNSAnnual Financial Report
8th Apr 20203:56 pmRNSStatement re Offer for Subscription
26th Mar 20205:25 pmRNSUpdate on Net Asset Value
26th Mar 20205:00 pmRNSAllotment Update and Suspension of DIS
20th Mar 20204:57 pmRNSTransaction in Own Shares
28th Feb 20204:56 pmRNSTransaction in Own Shares
24th Feb 20204:35 pmRNSStatement re Net Asset Value and Proposed Dividend
11th Feb 20205:04 pmRNSDirector/PDMR Shareholding
11th Feb 20205:02 pmRNSDirector/PDMR Shareholding
11th Feb 20204:24 pmRNSIssue of Equity
6th Feb 20203:39 pmRNSStatement re Offer for Subscription
18th Dec 20192:14 pmRNSDirectorate Change
18th Dec 20192:09 pmRNSMerger Update: Approval of Scheme
10th Dec 201912:30 pmRNSResult of General Meeting
14th Nov 20196:20 pmRNSStatement re Proposed Merger
14th Nov 20196:20 pmRNSStatement re Offer for Subscription
7th Nov 20192:11 pmRNSNet Asset Value(s)
4th Oct 201911:30 amRNSDirector/PDMR Shareholding
4th Oct 201910:22 amRNSIssue of Equity
1st Oct 201912:34 pmRNSNet Asset Value(s)
20th Sep 201912:44 pmRNSHalf-year Report
19th Sep 20193:46 pmRNSTransaction in Own Shares
17th Sep 20193:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.